ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients

Beneficios de la rilpivirina para la rigidez hepática en pacientes con coinfección por VIH/VHC

Carmen Busca Arenzanaa,

Corresponding author

carmenbusca@gmail.com

Corresponding author.

, Juan González-Garcíaa, Ana Blas-Garcíab,c, Juan V. Espluguesb,c,d,e, Antonio Olveira Martínf, Maria Luisa Montes Ramíreza

a Unidad VIH, Servicio de Medicina Interna, Hospital Universitario La Paz, Idipaz, Madrid, Spain

b Departamento de Fisiología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain

c Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Valencia, Spain

d Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain

e FISABIO-Hospital Universitario Dr. Peset, Valencia, Spain

f Unidad Hepatología, Servicio de Gastroenterología, Hospital Universitario La Paz, Madrid, Spain

Read

337

Times
was read the article

117

Total PDF

220

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2022.08.005

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	14	0	14
2024 October	34	12	46
2024 September	33	3	36
2024 August	29	7	36
2024 July	2	0	2
2024 April	5	0	5
2024 March	8	4	12
2024 February	94	33	127
2023 December	1	0	1
2023 March	0	3	3
2023 February	0	2	2
2023 January	0	4	4
2022 December	0	17	17
2022 November	0	32	32

Show all

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter